Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

4471 - 4480 of 44979 results found

BRD4354 Is a Potent Covalent Inhibitor against the SARS-CoV-2 Main Protease

Date
Thursday, February 08, 2024 - 4:00 AM
Description
Numerous organic molecules are known to inhibit the main protease (M^(Pro)) of SARS-CoV-2, the pathogen of Coronavirus Disease 2019 (COVID-19). Guided by previous research on zinc-ligand inhibitors of M^(Pro) and zinc-dependent histone deacetylases